MALCOLM BARRATT-JOHNSON

Managing Director, PharmaMedic Consultancy Ltd

Malcolm is medical doctor with over 24 years experience as a UK and European based Consultant Pharmaceutical Physician to Industry and Government. Managing Director of PMC- Pharmamedic Consultancy Ltd, the consultancy is a trusted partner to several pharmaceutical and biotech companies specialising in Medical Affairs, Product Development and Regulatory Strategy.

A previous Chair to the European Commission’s Biomedical Research Programme (Horizon 2020), he has lectured in both Europe and the United States on medicinal development, and is a lecturer on the MSc Drug Development Course at King’s College, London and to Imperial College, London on regulatory aspects of in vitro diagnostics.

He has had senior UK and Global consultancy positions with a wide range of companies including AstraZeneca, Eisai, Roche, Novartis, MSD, GSK, Celgene and Amgen, in addition to having advisory development roles in the wider biotech and generic pharma sectors. He holds Non-Executive Director positions with both NovaBiotics Ltd, an innovative and World leading antimicrobial company and MirZyme Ltd, a company developing diagnostics and treatments for pre-eclampsia.

Following a first degree in Physiology at King’s College London, Malcolm qualified in medicine from St Bartholomew’s Hospital, in 1993. After postgraduate training in General Medicine and Anaesthesiology he joined the then UK Government’s Medicines Control Agency (now MHRA), as a new medicines Medical Assessor in 1997. Lead Medical Assessor to the UK Dept of Health’s Clinical Trials Unit on it’s formation in 2005, he worked with European Medicines Evaluation Agency (EMA) colleagues on the development of the trans-European clinical trial pharmacovigilance systems. Leaving full time employment with the Agency in February 2007, Malcolm was appointed an Independent Consultant to the MHRA.

In 2012 he was appointed President to the Section of Pharmaceutical Medicine and Research at the Royal Society of Medicine, London and in 2014, a Fellow of The Royal Society of Biology.